Nidanilimab (Anti-IL-1RAP / IL-1R3)

Synonyms: CAN04

Nidanilimab (Anti-IL-1RAP / IL-1R3) is a fully humanized monoclonal antibody targeting IL1RAP and blocks IL1α and IL1β signaling. It also stimulates the immune system to destroy tumour cells. It can be used in treatment of non-small lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC). MW :143.56 KD.

Nidanilimab (Anti-IL-1RAP / IL-1R3)

Purity & Quality Control

Batch: A244401 Purity: 99% Protein concentration: 4.52mg/ml Endotoxin Level: <1EU/mg
99

Choose Selective Interleukins Inhibitors

Biological Activity

Description Nidanilimab (Anti-IL-1RAP / IL-1R3) is a fully humanized monoclonal antibody targeting IL1RAP and blocks IL1α and IL1β signaling. It also stimulates the immune system to destroy tumour cells. It can be used in treatment of non-small lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC). MW :143.56 KD.

Product Details

CAS No. 2171061-85-9
Molecular Weight 143.56 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Nidanilimab (Anti-IL-1RAP / IL-1R3) | Nidanilimab (Anti-IL-1RAP / IL-1R3) supplier | purchase Nidanilimab (Anti-IL-1RAP / IL-1R3) | Nidanilimab (Anti-IL-1RAP / IL-1R3) cost | Nidanilimab (Anti-IL-1RAP / IL-1R3) manufacturer | order Nidanilimab (Anti-IL-1RAP / IL-1R3) | Nidanilimab (Anti-IL-1RAP / IL-1R3) distributor